Clinical Trials
PF-08046054/SGN-PDL1V vs Docetaxel in patients with PD-L1+ NSCLC
Disease Type: Lung
A randomized, Phase 3, open-label study to evaluate PF-08046054/SGN-PDL1V vs Docetaxel in adult participants with previously-treated programmed cell death ligand (PD-L1) positive non-small cell lung cancer (NSCLC)
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville